|
|
|
Volumn 34, Issue 6, 2007, Pages 841-848
|
|
Medical treatment for stage III non-small-cell lung cancer (NSCLC)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
GEFITINIB;
MITOMYCIN;
PACLITAXEL;
QUINAZOLINE DERIVATIVE;
ADJUVANT THERAPY;
ARTICLE;
CANCER STAGING;
DRUG ADMINISTRATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
LUNG TUMOR;
LYMPH NODE;
LYMPH NODE METASTASIS;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
RADIATION DOSE;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LUNG NEOPLASMS;
LYMPH NODES;
LYMPHATIC METASTASIS;
MITOMYCIN;
NEOPLASM STAGING;
PACLITAXEL;
PNEUMONECTOMY;
QUINAZOLINES;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
SURVIVAL RATE;
|
|
EID: 34447617887
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
